Medicine by Design-funded researchers devise new strategy to improve the safety of cell therapies
Please click here to read the original version of the article that first appeared on Medicine by Design’s site and is reprinted with permission. The article has been edited slightly for length. A contagious facial cancer that has ravaged Tasmanian devils in southern...A firm hand for the regenerative medicine industry
An experienced cell and gene therapy development executive with extensive surgical and medical clinical experience, Dr. Sven Kili is focused on delivering positive ethical outcomes for patients and customers. Sven is currently the VP and Head of Cell & Gene...The long road to commercialization
Carmen Wong completed her PhD studies on creating viruses for cancer research. Since then, she has been working with inventors from universities, accelerators, and startup companies to commercialize their innovations. Carmen was a commercialization analyst with CCRM...Right Turn: The ABCs of IP and CEO
For Canada to thrive, supporting and training our future work force and leaders is crucial. This can happen in a myriad of ways. For a group of Canadian organizations in the biotherapeutics field, this has taken the form of joining together to host training workshops...
Comments